Regen BioPharma Inc (RGBP): EPS (Basic)
-$0.05
Year ended 2025-09-30
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$0.05 | n/m | 2025-12-30, From 2024-10-01 |
| 2024-09-30 | -$0.16 | n/m | 2025-12-30, From 2023-10-01 |
| 2023-09-30 | $0.29 | -59.2% | 2025-05-13, From 2022-10-01 |
| 2022-09-30 | $0.71 | n/a | 2023-11-20, From 2021-10-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$0.05 | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$2.65 | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$0.39 | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$4.86 | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$0.78 | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$1.91 | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$0.01 | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$5.97 | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$0.24 | n/m |
Compare RGBP, CLNN, ABVC, HIND side by side · Screen every company in Pharmaceutical Preparations ↗